Clinical Trial

Rituximab Combined With Prior Therapy in Advanced Hepatocellular Carcinoma: Efficacy & Safety Study

Recruiting Phase 2
View on ClinicalTrials.gov →
Record status
This record was last updated November 20, 2024 (before its estimated December 31, 2025 completion). Its status may not reflect the trial's current state.
Summary
Evaluation of the efficacy and safety of adding rituximab after failure of target immunotherapy in the Posterior treatment of advanced hepatocellular carcinoma
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-03-03.
Status change: Not Yet Recruiting → Recruiting 2024-11-17
Trial Details
NCT Number NCT06301399
Lead Sponsor Tianjin Medical University Cancer Institute and Hospital
Conditions Advanced Hepatocellular Carcinoma
Enrollment 20 participants
Start Date 2024-03-20
Primary Completion 2025-12-31 (estimated)
Study Completion 2026-12-31 (estimated)
Updated on ClinicalTrials.gov 2024-11-20